Direct-to-Consumer Drug Ads Come Under Scrutiny (HealthDay)


HealthDay - THURSDAY, Nov. 3 (HealthDay News) -- Federal health officials heard widely divergent opinions on direct-to-consumer advertising of prescription drugs during public hearings Tuesday and Wednesday, with industry groups claiming the ads lead to better health care and consumer groups suggesting they can mislead the public.